Adial Pharmaceuticals News

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

Mar 27 18:25 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Newman James W. Jr.

Mar 27 18:25 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Truluck Joseph

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Claiborne Cary J

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Anderson J. Kermit

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goodman Tony

Mar 27 18:10 ET

Adial Pharmaceuticals | D: Filing D

Mar 14 17:16 ET

Adial Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 14 15:25 ET

Adial Pharmaceuticals | D: Filing D

Oct 26, 2023 17:20 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin

Oct 3, 2023 08:54 ET

Adial Pharmaceuticals | D: Filing D

Jun 2, 2023 17:58 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Johnson Bankole A.

Jun 2, 2023 07:52 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Truluck Joseph

May 25, 2023 16:50 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stilley William B. III

May 25, 2023 16:47 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin

May 25, 2023 16:45 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Newman James W. Jr.

May 25, 2023 16:43 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Goodman Tony

May 25, 2023 16:41 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

May 25, 2023 16:38 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Claiborne Cary J

May 25, 2023 16:36 ET